CGT 4255
Alternative Names: CGT-4255Latest Information Update: 15 Apr 2024
At a glance
- Originator Cogent Biosciences
- Class Antineoplastics; Small molecules
- Mechanism of Action ERBB 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer